Welcome to China Medilcai System Holdings Ltd's Investor Relations section.

The CMS Group is an integrated and profitable pharmaceutical group focusing on research and development, manufacturing, distributing and marketing of prescription drugs, pharmaceutical products and medical equipment primarily in China . Through years of continued and diligent effort from our dedicated employees and management team, CMS Group has been one of the most profitable pharmaceurical companies in China .

The section contains most information which is required to be disclosed in accordance with Rule 26 of the AIM rules (February 2007).